Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-15 | 88.0 | 45 | |
0 | IL-15 | 123.0 | 72 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 146.0 | 55 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 142.0 | 69 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 117.0 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 146.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 127.0 | 56 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 134.0 | 71 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 159.0 | 68 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 151.5 | 50 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 160.0 | 79 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 156.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 104.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 126.0 | 90 | |
RA2159 | 3 | IL-15 | 105.0 | 55 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-15 | 117.0 | 49 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-15 | 118.0 | 55 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-15 | 108.5 | 64 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 119.0 | 67 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-15 | 111.0 | 61 | ||||
RA2159 | 3 | IL-15 | 107.0 | 88 | |||||||
N2586 | 3 | IL-15 | 111.5 | 56 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL-15 | 120.0 | 79 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-15 | 111.0 | 63 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-15 | 124.0 | 65 |